The mechanism of zinc absorption has not been delineated, but kinetic studies show that both passive and carrier-mediated processes are involved. We have identified a low molecular mass zinc-binding protein in the soluble fraction of rat intestinal mucosa that could function as an intracellular zinc carrier. The protein was not detected in liver or pancreas, suggesting a role specific to the intestine. The protein binds zinc during transmucosal zinc transport and shows signs of saturation at higher luminal zinc concentrations, characteristics consistent with a role in carrier-mediated zinc absorption. Microsequence analysis of the protein purified by gel-filtration HPLC and SDS/PAGE showed complete identity within the first 41 N-terminal amino acids with the deduced protein sequence of cysteine-rich intestinal protein [Birkenmeier, E. H. & Gordon, J. I. (1986) Proc. Nal. Acad. Sci. USA 83, 2516USA 83, -2520. These investigators showed that the gene for this protein is developmentally regulated in neonates during the suckling period, conserved in many vertebrate species, and predominantly expressed in the small intestine. Cysteine-rich intestinal protein contains a recently identified conserved sequence of histidine and cysteine residues, the LIM motif, which our results suggest confers metal-binding properties that are mportant for zinc transport and/or functions of this micronutrient.
Dietary Zn is absorbed primarily by the small intestine, but the mechanism(s) has not been identified (1) (2) (3) . The process may be energy dependent (4, 5) and is inversely related to the intracellular concentration of intestinal metallothionein (2, 6) , a low molecular mass protein that binds Zn, Cu, Cd, and other trace elements. Kinetic analyses have shown that Zn absorption includes both passive diffusion and carriermediated components (7) (8) (9) that may represent paracellular and transcellular absorption pathways. Carrier-mediated Zn absorption is increased in Zn-deficient animals, suggesting up-regulation of the carrier system (7, 9) .
Using gel-filtration HPLC, we identified a low molecular mass, intracellular constituent from rat intestinal mucosa that binds Zn during transmucosal Zn transport (10) . It was not metallothionein, based on Cd-hemoglobin affinity assay.
When 65Zn was introduced into ligated duodenal loops, the proportion of intracellular 65Zn associated with this constituent was reduced when chelating agents that reduced Zn absorption were also present. This suggested a functional role in Zn absorption.
In the present study, we used a combination of gelfiltration HPLC, SDS/PAGE, and Western blotting to show that the 65Zn-binding constituent is a protein that is present in the intestine but not in liver or pancreas. The amino acid sequence of the purified protein is identical to the deduced sequence of cysteine-rich intestinal protein (CRIP), encoded by a developmentally regulated mRNA identified by Birkenmeier and Gordon (11) . Our data suggest that CRIP has a role in Zn absorption and may function as an intracellular Zn transport protein.
MATERIALS AND METHODS Animals. Male Sprague-Dawley strain rats (Harlan SpragueDawley) weighing 150-200 g were maintained as described (10) . Tap water and a commercial, nonpurified diet (Rodent Laboratory Chow 5001, Ralston Purina) containing =70 mg of Zn per kg were supplied ad libitum.
Sample Preparation. Intestinal proteins were labeled with 65Zn by introducing 0.5 ml of saline containing 185 kBq of 65Zn (DuPont/NEN, 68 kBq of 65Zn per nmol of Zn) into 10-cm ligated loops of the proximal small intestine of anesthetized rats (10) . The Zn concentration of the injected solution was adjusted when necessary by adding ZnSO4. After 15 min, the segment was drained and rinsed with ice-cold homogenization buffer [10 mM Tris'HCl (pH 8.6) containing 154 mM NaCl, 0.02% NaN3, 0.2 mM phenylmethylsulfonyl fluoride, and 0.6 ,ug of leupeptin and 0.9 ,ug of pepstatin A per ml], and the mucosal layer was collected. Samples of liver and pancreas were labeled for 15 min with 65Zn by injecting 1100 kBq of65Zn into the hepatic portal vein.
Homogenates of liver, pancreas, and intestinal mucosa were prepared 1:3 (wt/vol) in homogenization buffer by using a Potter-Elvehjem, glass-Teflon tissue grinder. After centrifugation at 40,000 X g for 30 min at 4°C, the supernatant fraction (hereafter referred to as cytosol) was filtered (0.2 ,um), and the soluble proteins were separated by gel-filtration HPLC.
Gel-Filtration HPLC. Samples were eluted from two 1 x 30 cm Superose 12 columns (Pharmacia) connected in series at 0.5 ml/min [-400 psi (1 psi = 6.89 kPa) with 10 mM Tris-HCl (pH 8.6) containing 154 mM NaCI, 10 mM MgSO4, and 0.02% NaN3]. HPLC fractions (0.5 ml) were measured for 65Zn by y spectrometry, total Zn was assayed by air-acetylene flame atomic absorption spectrophotometry (10) , and metallothionein concentration was determined by Cd-hemoglobin affinity assay (12) . All chromatographic profiles shown are representative of three or more runs of samples from different animals.
SDS/PAGE. Selected HPLC fractions were concentrated by ultrafiltration (Mr > 3000; Centricon-3, Amicon), and the proteins were resolved further by discontinuous SDS/PAGE on 15% Tris-tricine/polyacrylamide gels (13 tTo whom reprint requests should be addressed.
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RESULTS
Identification of a Zn-Binding Protein Specific to the Intestine. A 6-to 9-kDa 65Zn peak was identified in the intestinal mucosal cytosol by gel-filtration HPLC (Fig. 1) . A comparable peak was not detected in cytosol from either liver or pancreas. The peak did not comprise metallothionein, which was eluted earlier and was observed in all three tissues. A large proportion of the intracellular 65Zn from the intestinal mucosa was associated with this peak 15 min after 65Zn was introduced into the lumen. This suggests that a constituent eluting in this peak avidly binds Zn'during transmucosal Zn transport.
Fractions eluting at the same volume (Ve = 30.5-32.5 ml) as the intestinal 65Zn peak were collected from each tissue, further resolved by SDS/PAGE, and transferred onto nitrocellulose. Staining with amido black and labeling with 65Zn ( Fig. 2) Proc. Natl. Acad. Sci. USA 88 (1991) possible role of CRIP as a Zn transport protein was obtained by evaluating the intracellular distribution of total Zn and of 65Zn when the luminal Zn level was above or below this saturation concentration (Fig. 4) . Since the 65Zn was introduced directly into the lumen of the intestine, it served as a tracer for the movement of luminal Zn during transmucosal transport.
CRIP bound nearly halfofthe Zn entering the cells from the lumen [42 + 4% (SD) of the 65Zn] but only 11 ± 2% (SD) of the total Zn in the cytosol (measured by atomic absorption spectrophotometry) when the luminal Zn concentration was 5 MM-i.e., below the saturation concentration for carriermediated Zn absorption (Fig. 4) . The higher specific activity of CRIP compared with the average of all other Zn-binding constituents in the cytosol (1.15 vs. 0.18 Bq of 65Zn per pmol ofZn) suggests that the greater accumulation of65Zn by CRIP represents a much greater interaction with 65Zn entering the cell from the lumen, as might be expected of a carrier protein.
In contrast, when the luminal Zn concentration was 300 AM, or well above the saturation concentration for carriermediated Zn absorption (Fig. 4) , CRIP bound only 25 ± 2% (SD) of the 65Zn in the cytosol. The lower proportion of 65Zn associated with CRIP at the higher luminal Zn concentration could indicate that carrier-mediated Zn transport-was saturated and that excess Zn entering the cell from the lumen was associated with intracellular constituents other than the carrier protein. This is supported by the observation that neither total Zn (Fig. 4) nor the proportion of total intracellular Zn (9 ± 2% SD) bound to CRIP was different at the higher luminal Zn concentration, suggesting that CRIP has a limited Znbinding capacity. The specific activity of CRIP was still greater than the average of all other intracellular Zn-binding constituents (0.28 vs. 0.08 Bq of 65Zn per pmol of Zn), indicating greater interaction with luminal Zn even at the higher luminal Zn concentration.
DISCUSSION
Birkenmeier and Gordon (11) showed that CRIP mRNA is most abundant in adult rodent small intestine and more abundant in villus than crypt cells. Similar levels of CRIP mRNA were observed in duodenum, jejunum, and ileum, while the colon contained 46% of that observed in the small intestine. Much less was reported in other tissues compared with that in the small intestine, including lung (15%), spleen (12%), adrenal (9%), and testis (8%). CRIP mRNA was not detected in brain, kidney, or liver. The CRIP gene sequence is conserved in many vertebrate species and expressed specifically in the intestine, indicating a fundamental role in nutrient absorption or intestinal metabolism. Our data show that CRIP binds Zn during transmucosal Zn transport and could be involved in carrier-mediated Zn absorption.
CRIP may function as an intracellular Zn carrier with a role analogous to that proposed for calbindin in calcium absorption. Calbindin purportedly facilitates calcium absorption (14, 15) by competitively binding calcium at the brush border, increasing the intracellular concentration of diffusible calcium (i.e., calcium that moves through the cell to the basolateral membrane). Parallels between Zn and calcium absorption kinetics and between CRIP and calbindin, respectively, suggest that calcium and Zn absorption mechanisms may have some similar characteristics. Both nutrients are absorbed by passive and carrier-mediated transport mechanisms (7, 9, 14) , and both carrier-mediated mechanisms are developmentally regulated (14, 16) . Intestinal levels of CRIP mRNA (11) and calbindin (14) reflect these developmental changes in carrier-mediated transport, suggesting that CRIP, like calbindin, could have a functional role in mineral absorption.
The developmental regulation of CRIP and its possible role in Zn absorption suggest an involvement in acrodermatitis enteropathica, a human autosomal recessive Zn malabsorption disease (17 novel, cysteine-rich LIM motif [Cys-Xaa2-Cys-Xaa17_19-HisXaa2-Cys-Xaa2-Cys-Xaa2-Cys-Xaa7_1l-(Cys)-Xaa8-Cys] recently described by Freyd et al. (ref. 18 ; named LIM for the same cysteine-rich motif of lin-il, isl-), and mec-3 genes). Because of the metal-binding attributes likely afforded by the cysteine and histidine residues, they suggested that the LIM motif has a metal-binding function similar to that of the consensus motifs of Zn fingers in transcription factors. Our data demonstrate that CRIP binds Zn and strongly supports a metal-binding function for the LIM motif. CRIP differs from other LIM proteins (18) (19) (20) because it contains one copy of the motif rather than two and also lacks a homeodomain that would promote binding to DNA. The function of the LIM motif is unknown, but presumably it stabilizes proteinprotein and/or protein-nucleic acid interactions (18) . Our results suggest that the LIM motif in CRIP could facilitate the protein's interaction with Zn atoms during transport. The resulting conformational change could facilitate transcellular Zn movement or promote site recognition for interaction with other specific components of the Zn transport mechanism. Stoichiometry of Zn binding remains to be determined when more of the protein is available. The LIM motif provides seven cysteine residues and one histidine residue. These ligands could produce Zn "finger," "cluster," and/or "twist" structures (21) . A conservative estimate would be two or three Zn atoms per molecule of CRIP. Alternatively, the similarity of the CRIP sequence to bacterial ferredoxins was noted (11) . This could suggest a role in binding of other metals through sulfur cluster formation.
Zeng et al. (22) (27) and by changes in metallothionein mRNA (28) . However, other studies that have used only gel-filtration chromatography to measure changes in intestinal metallothionein must be reevaluated, since the reported results could reflect changes in metallothionein, CRIP, or both proteins.
The role of CRIP in Zn metabolism or a role of Zn in CRIP function must be confirmed. Our data show that CRIP interacts avidly with Zn during transmucosal Zn transport and suggest a role in carrier-mediated Zn absorption. A role in Zn absorption, homeostasis, or function will be strengthened by evidence that expression of the CRIP gene is regulated by Zn status, other nutrients, or hormonal factors.
